Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination - Kato, Hideaki; Miyakawa, Kei; Ohtake, Norihisa; Yamaoka, Yutaro; Yajima, Satoshi; Yamazaki, Etsuko; Shimada, Tomoko; Goto, Atsushi; Nakajima, Hideaki; Ryo, Akihide (Vaccine, 2022)
Keywords: 50% neutralization titer; Adult; Age; Alcohol; alcohol drinking; Allergy and Immunology; Antibodies; Antibodies, Neutralizing; Antibodies, Viral; BNT162 Vaccine; Body mass index; Cell-mediated immunity; confidence interval; Confidence intervals; Coronavirus disease-2019; Coronaviruses; COVID-19 - prevention & control; COVID-19 vaccines; Enzyme-linked immunosorbent assay; Enzymes; gender; Humans; Humoral immunity; IgG antibody; Immune response (humoral); Immunity; Immunity, Cellular; Immunity, Humoral; Immunoassay; Immunoglobulin G; Infections; Interferon; Interferon-γ releasing ELISpot assay; Proteins; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Short Communication; Software; Spike Glycoprotein, Coronavirus; Spike protein; Vaccination; Vaccines; Variant of concern; γ-Interferon; United States--US; Japan; Coronavirus disease-2019; Cell-mediated immunity; Variant of concern; Vaccination; Interferon-γ releasing ELISpot assay; 50% neutralization titer